{
    "clinical_study": {
        "@rank": "151292", 
        "arm_group": [
            {
                "arm_group_label": "Group A", 
                "arm_group_type": "Active Comparator", 
                "description": "tidal volume setting of 6ml/kg with the -7cm H2O ITPR as first device"
            }, 
            {
                "arm_group_label": "Group B", 
                "arm_group_type": "Active Comparator", 
                "description": "tidal volume setting of 8ml/kg with the -7cm H2O ITPR as first device"
            }, 
            {
                "arm_group_label": "Group C", 
                "arm_group_type": "Active Comparator", 
                "description": "tidal volume setting of 6ml/kg with the -12cm H2O ITPR as first device"
            }, 
            {
                "arm_group_label": "Group D", 
                "arm_group_type": "Active Comparator", 
                "description": "tidal volume setting of 8ml/kg with the -12cm H2O ITPR as first device"
            }
        ], 
        "brief_summary": {
            "textblock": "The purpose of this study is to demonstrate proof of clinical concept that application of\n      the Intrathoracic Pressure Regulator (ITPR) will result in an increase in Cerebral Perfusion\n      Pressure (CPP) and a decrease in Intracranial Perfusion Pressure (ICP) in patients with head\n      injury and elevated ICP, and to determine the optimal ventilation tidal volume (TV)."
        }, 
        "brief_title": "Effect of Intrathoracic Pressure Regulation on Traumatic Brain Injury", 
        "condition": "Head Injury", 
        "condition_browse": {
            "mesh_term": [
                "Craniocerebral Trauma", 
                "Intracranial Hypertension", 
                "Brain Injuries", 
                "Wounds and Injuries"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  \u226515 years of age\n\n          -  intubated and mechanically ventilated on a volume controlled mode\n\n          -  head injury or other intracranial pathology with ICP of \u226515 mmHg\n\n          -  arterial line in place\n\n          -  SpO2 \u226595%\n\n          -  MAP >60\n\n          -  in ICU or about to undergo neurosurgery with planned placement of an ICP monitor\n\n          -  inclusion presents no significant delays to planned emergent neurosurgery\n\n          -  prior written informed consent\n\n        Exclusion Criteria:\n\n          -  cardiac or pulmonary injury impacting intrathoracic pressure\n\n          -  confirmed pneumothorax or hemothorax\n\n          -  PaO2/FiO2 <300\n\n          -  serious neck injury resulting in neck swelling with jugular venous compression\n\n          -  evidence of ongoing uncontrolled bleeding\n\n          -  respiratory disease such as COPD, interstitial lung disease, or other parenchymal or\n             pulmonary vascular disease\n\n          -  congestive heart failure"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "15 Years"
        }, 
        "enrollment": {
            "#text": "40", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "March 29, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01824589", 
            "org_study_id": "ACSI W81XWH-11-1-0542", 
            "secondary_id": "W81XWH-11-1-0542"
        }, 
        "intervention": [
            {
                "arm_group_label": [
                    "Group A", 
                    "Group B"
                ], 
                "description": "Single use disposable non-invasive device that is connected to a vacuum source and a means to deliver a positive pressure breath and generates negative3 pressure during the expiratory phase, thus creating subatmospheric intrathoracic pressure of -7 cmH2O between periods of positive pressure ventilations.", 
                "intervention_name": "-7 cm H2O ITPR", 
                "intervention_type": "Device", 
                "other_name": "Intrathoracic Pressure Regulator, CirQlator"
            }, 
            {
                "arm_group_label": [
                    "Group C", 
                    "Group D"
                ], 
                "description": "Single use disposable non-invasive device that is connected to a vacuum source and a means to deliver a positive pressure breath and generates negative3 pressure during the expiratory phase, thus creating subatmospheric intrathoracic pressure of -12 cmH2O between periods of positive pressure ventilations.", 
                "intervention_name": "-12cm H2O ITPR", 
                "intervention_type": "Device", 
                "other_name": "Intrathoracic Pressure Regulatory, CirQlator"
            }
        ], 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "keyword": [
            "traumatic brain injury", 
            "TBI", 
            "ITPR", 
            "intrathoracic pressure regulator", 
            "hepatic encephalopathy", 
            "pseudotumorcerebri", 
            "obstructive hydrocephalus", 
            "intracranial hemorrhage"
        ], 
        "lastchanged_date": "April 2, 2013", 
        "number_of_arms": "4", 
        "official_title": "Effects of Intrathoracic Pressure Regulation Therapy in Patients With Elevated Intracranial Pressure Due to Brain Injury or Intracranial Pathology", 
        "overall_status": "Active, not recruiting", 
        "oversight_info": {
            "authority": "United States: Institutional Review Board", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 4", 
        "primary_completion_date": {
            "#text": "August 2013", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Change in ICP from baseline will be compared with the ICP during 15 minutes of ITPR use.", 
            "measure": "Intracranial Pressure (ICP)", 
            "safety_issue": "No", 
            "time_frame": "15 minutes after device is activated"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01824589"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "description": "Measurement of the mean and max CPP during ITPR use and time to maximum increase in CPP.", 
                "measure": "Cerebral Perfusion Pressure (CPP)", 
                "safety_issue": "No", 
                "time_frame": "15 minutes after device activation"
            }, 
            {
                "description": "Change in lung compliance following each ITPR treatment and 20 minutes following removal of the ITPR compared to baseline.", 
                "measure": "Lung compliance", 
                "safety_issue": "No", 
                "time_frame": "baseline and up to 20 minutes after device removal"
            }, 
            {
                "description": "Arterial blood gases will be collected and compared to baseline values.", 
                "measure": "Arterial blood gases", 
                "safety_issue": "Yes", 
                "time_frame": "15 minutes after device activation"
            }
        ], 
        "source": "Advanced Circulatory Systems", 
        "sponsors": {
            "collaborator": {
                "agency": "U.S. Army Medical Research and Materiel Command", 
                "agency_class": "U.S. Fed"
            }, 
            "lead_sponsor": {
                "agency": "Advanced Circulatory Systems", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "August 2012", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Crossover Assignment, Masking: Single Blind (Subject), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "April 2013"
    }
}